Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bruno

Showing results (311-320 of 355) with videos related to

Pageof 36
Sort By:
Cancer Immunology Research|May 19, 2022
Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T CellsAshwin Somasundaram, Anthony R Cillo, Caleb Lampenfeld, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) reviewAlessandra Cesano, Ryan Augustin, Luigi Barrea, et al.
Materials (Basel, Switzerland)|December 15, 2019
Scanning Magnetic Microscope Using a Gradiometric Configuration for Characterization of Rock SamplesJefferson F D F Araujo, Andre L A Reis, Angela A P Correa, et al.
Neurology|November 4, 2006
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophyE Mercuri, E Bertini, S Messina, et al.
Cell|May 30, 2017
Interferon-γ Drives T<sub>reg</sub> Fragility to Promote Anti-tumor ImmunityAbigail E Overacre-Delgoffe, Maria Chikina, Rebekah E Dadey, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanomaLilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.
Nature Communications|June 8, 2021
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T Ruffin, Anthony R Cillo, Tracy Tabib, et al.
Neuromuscular Disorders : NMD|January 24, 2006
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric studyE Mercuri, S Messina, R Battini, et al.
Frontiers in Immunology|May 24, 2021
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in GlioblastomaItay Raphael, Rajeev Kumar, Lauren H McCarl, et al.
Nature Communications|December 18, 2021
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencingCornelius H L Kürten, Aditi Kulkarni, Anthony R Cillo, et al.
Pageof 36

Showing results (311-320 of 355) with videos related to

Sort By:
Pageof 36
Cancer Immunology Research|May 19, 2022
Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T CellsAshwin Somasundaram, Anthony R Cillo, Caleb Lampenfeld, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) reviewAlessandra Cesano, Ryan Augustin, Luigi Barrea, et al.
Materials (Basel, Switzerland)|December 15, 2019
Scanning Magnetic Microscope Using a Gradiometric Configuration for Characterization of Rock SamplesJefferson F D F Araujo, Andre L A Reis, Angela A P Correa, et al.
Neurology|November 4, 2006
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophyE Mercuri, E Bertini, S Messina, et al.
Cell|May 30, 2017
Interferon-γ Drives T<sub>reg</sub> Fragility to Promote Anti-tumor ImmunityAbigail E Overacre-Delgoffe, Maria Chikina, Rebekah E Dadey, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanomaLilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.
Nature Communications|June 8, 2021
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T Ruffin, Anthony R Cillo, Tracy Tabib, et al.
Neuromuscular Disorders : NMD|January 24, 2006
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric studyE Mercuri, S Messina, R Battini, et al.
Frontiers in Immunology|May 24, 2021
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in GlioblastomaItay Raphael, Rajeev Kumar, Lauren H McCarl, et al.
Nature Communications|December 18, 2021
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencingCornelius H L Kürten, Aditi Kulkarni, Anthony R Cillo, et al.
Pageof 36